SUBSCRIBE
SUBSCRIBE
News   FDA

U.S. FDA Clears Dendreon Corporation’s Prostate Cancer Vaccine

April 29, 2010 | 
1 min read

Reuters -- Dendreon Corp won U.S. approval on Thursday to sell a vaccine to treat men with advanced prostate cancer and the company’s shares soared 15 percent.

FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Cancer
BeiGene Gets Yet Another Label Expansion for PD-1 Drug Tevimbra
March 4, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Roche's tower in Shanghai, China
Approvals
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
March 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac